LRRK2 and Parkinson disease: Pathological studies of Parkinson's disease (PD) have shown that pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2) gene result in increased LRRK2 kinase activity, thereby promoting disease progression.